NASDAQ:AVGR - Avinger Stock Price, Forecast & News

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

Shares of Avinger reverse split before market open on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.

Avinger Inc (NASDAQ:AVGR) released its quarterly earnings results on Tuesday, November, 5th. The medical device company reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.60) by $0.10. The medical device company earned $2.41 million during the quarter. Avinger had a negative net margin of 237.51% and a negative return on equity of 197.22%. View Avinger's Earnings History.

Avinger is scheduled to release their next quarterly earnings announcement on Wednesday, March 4th 2020. View Earnings Estimates for Avinger.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Avinger.

Press coverage about AVGR stock has trended somewhat negative on Saturday, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Avinger earned a news impact score of -1.5 on InfoTrie's scale. They also gave headlines about the medical device company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Avinger.

Avinger saw a drop in short interest in October. As of October 15th, there was short interest totalling 63,200 shares, a drop of 79.0% from the September 15th total of 300,800 shares. Based on an average daily trading volume, of 423,200 shares, the short-interest ratio is presently 0.1 days. Approximately 1.0% of the shares of the company are sold short. View Avinger's Current Options Chain.

Some companies that are related to Avinger include T2 Biosystems (TTOO), Apollo Endosurgery (APEN), Motus GI (MOTS), Nephros (NEPHD), BeyondAirInc . (XAIR), Arch Therapeutics (ARTH), AIT Therapeutics (AITB), SANUWAVE Health (SNWV), Endologix (ELGX), Invo Bioscience (IVOB), PAVmed (PAVM), Neovasc (NVCN), Titan Medical (TMDI), DarioHealth (DRIO) and Biostage (BSTG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Avinger investors own include AcelRx Pharmaceuticals (ACRX), Aralez Pharmaceuticals (ARLZ), Palatin Technologies (PTN), Micron Technology (MU), Alibaba Group (BABA), AVEO Pharmaceuticals (AVEO), Biocept (BIOC), Bellerophon Therapeutics (BLPH), Histogenics (HSGX) and SCYNEXIS (SCYX).

(AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company acted as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

Avinger's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Perkins Capital Management Inc. (12.36%), Wedbush Securities Inc. (1.18%) and Virtu Financial LLC (0.43%). View Institutional Ownership Trends for Avinger.

AVGR stock was purchased by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., Wedbush Securities Inc. and Virtu Financial LLC. View Insider Buying and Selling for Avinger.

Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AVGR stock can currently be purchased for approximately $1.42.

Avinger has a market capitalization of $14.70 million and generates $7.91 million in revenue each year. The medical device company earns $-27,560,000.00 in net income (profit) each year or ($33.40) on an earnings per share basis. View Additional Information About Avinger.

The official website for Avinger is http://www.avinger.com/.

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected]